Every DSIP (Delta Sleep-Inducing Peptide) Question Answered, in 16 Studies

16 referenced articles

• What Is DSIP? The Nonapeptide Named for an EEG Effect4 sources
• The Barrier Any Central Claim Has to Cross3 sources
• What the Field Said After Its First Decade2 sources
• A Question Mark in the Title Is Doing Real Work2 sources
• What Adrenalectomy Changed3 sources
• What the Antibody Found in Peripheral Tissue2 sources
• An Antibody Reports What It Binds, Not What Is There3 sources
• DSIP Regulatory Status4 sources
• DSIP in the Published Literature3 sources
• DSIP Storage, Stability and Reconstitution3 sources
• DSIP CAS Number and Chemical Identity2 sources
• DSIP Structure, Sequence and Physical Properties2 sources
• What Delta Waves Are, and Why DSIP Is Named for Them2 sources
• The Missing Biology: No Gene, No Precursor, No Receptor3 sources
• How DSIP Was Discovered3 sources
• Does DSIP Actually Induce Sleep? What the Evidence Shows3 sources

Open research questions

• What is DSIP?
• Does DSIP actually induce sleep?
• How was DSIP discovered?
• Does DSIP have a receptor?
• What are delta waves?
• Is DSIP approved anywhere?

Deep dive: a name that was a hypothesis, not a finding

In 1977 the Schoenenberger-Monnier group in Basel electrically stimulated the thalamus of a sleeping rabbit, collected blood draining from its brain, isolated a peptide fraction, and reported that administering it into the ventricles of awake rabbits produced delta-wave EEG activity. They named it delta sleep-inducing peptide. By the standards of the time this was careful, imaginative work, and they followed it properly - the 1978 Pflugers Archiv paper reported sequence, synthesis and activity of the synthetic nonapeptide rather than stopping at a suggestive fraction. The problem is not the original research. It is that a name recording a hypothesis has been read ever since as a summary of established pharmacology, and almost nobody checks whether it was earned.

Deep dive: the three things that are missing

A proposed endogenous peptide becomes accepted biology by a recognisable route. The gene is located. The precursor protein is characterised. A receptor is identified, giving a mechanism and a testable target. DSIP has completed none of these in nearly fifty years. The receptor gap is the most disabling - without one there is no mechanism to test, no dose-response to build, no antagonist to design, and no way to establish that an observed effect runs through the proposed pathway at all. The gene gap is the hardest to explain away: modern genomics located MOTS-c inside a short open reading frame nested within the mitochondrial 12S rRNA gene, sequence already annotated as something else. That a peptide described in 1977 still has no identified gene in any genome is a substantive observation, not an accident of effort.

Deep dive: why 519 papers is not 519 confirmations

DSIP has roughly 519 indexed PubMed records - more than Selank's 135 or Semax's 231. Publication volume tracks how interesting a question is, not how well it has been answered. A tractable question generates a burst of work and then stops; a question that resists resolution generates papers indefinitely, each a further attempt rather than a further confirmation. Kovalzon's 2006 review in the Journal of Neurochemistry states the field's own assessment in its title: a still unresolved riddle. Reading any individual DSIP paper without that context invites mistaking activity for consensus.

Handling checklist

• Store lyophilised material cold, dry and protected from light
• No reducing agent needed — the sequence contains no cysteine
• No methionine oxidation to expect; a +16 Da satellite warrants explanation
• Protect from prolonged light — the single tryptophan is mildly photosensitive
• Expect pH-dependent solubility; the peptide is strongly acidic with no basic residue
• Aliquot to avoid repeated freeze-thaw cycles

Common mistakes

Treating the name as evidence of the effect

The name records a 1977 hypothesis from a single rabbit EEG study. It is not a summary of established pharmacology.

Citing the 1977 paper as proof DSIP induces sleep

It reports delta-wave EEG activity in rabbits after intraventricular administration — a narrower claim than inducing sleep, in one species, by a route that bypasses every normal barrier.

Assuming DSIP is an established endogenous human peptide

No gene has been identified in any species, no precursor characterised and no receptor found.

Reading 519 papers as 519 confirmations

Volume reflects an unresolved question attracting sustained attempts, not accumulated confirmation.

Making any sleep claim about supplied material

The evidence does not support it and a therapeutic claim about research material is what MHRA enforcement targets.